Inovio And Collaborators Receive NIH Grant To Evaluate HIV Immunotherapy PENNVAX®-GP’s Ability To Induce … – Clinical Leader
Philly.com |
Inovio And Collaborators Receive NIH Grant To Evaluate HIV Immunotherapy PENNVAX®-GP's Ability To Induce …
Clinical Leader This is a two-step clinical study in HIV-positive subjects to assess Inovio's HIV immunotherapy PENNVAX-GP with INO-9012 (an IL-12 immune activator) alone and with the addition of a PD-1 checkpoint inhibitor. All trials will be randomized, double-blind … Inovio Pharmaceutical's DNA vaccine will be tested in patients with HIV Immune Check Activators Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024 |
